ArticleCancers2020
Combination of Peri-Tumoral and Intra-Tumoral Radiomic Features on Bi-Parametric MRI Accurately Stratifies Prostate Cancer Risk: A Multi-Site Study.
Abstract read
In one paragraph
Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 2 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
55 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Artificial-intelligence models vs. radiologists in the detection of clinically significant prostate cancer on mpMRI: a meta-analysis.European radiology · 2026Pooled it
- Radiomics in prostate cancer imaging for a personalized treatment approach - current aspects of methodology and a systematic review on validated studies.Theranostics · 2021Pooled it
- Precision Risk Stratification in Prostate Cancer: Unveiling MRI-Based Habitat-Driven Radiomics Model for Enhanced Treatment Guidance.Journal of imaging informatics in medicine · 2026Article
- A stacked multi-classifier for multi-modal data fusion in transcranial sonography-based Parkinson's disease assessment.NPJ Parkinson's disease · 2026Article
- From prostate-specific antigen to precision: The future of prostate cancer diagnosis with artificial intelligence, biomarkers, and imaging.Current urology · 2026Review
- From imaging to omics: deep learning is bridging MRI and liquid biopsy in bone tumor diagnosis.Journal of bone oncology · 2026Review
- Temporal-spatial evolution of tumor habitat analysis: a bibliometric study on research hotspots and trends in medical imaging (2014-2025).Translational cancer research · 2026Article
- Optimal peritumoral regions and fusion strategies for prediction of the double-expressor subtype in diffuse large B-cell lymphoma: a multi-region radiomics study.Frontiers in oncology · 2026Article
- Beyond PSA: The Future of Prostate Cancer Diagnosis Using Artificial Intelligence, Novel Biomarkers, and Advanced Imagery.Life (Basel, Switzerland) · 2025Review
- Radiomics Features from Different Prostatic Zones onCancers · 2025Article
- Preoperative MRI-based radiomics analysis of intra- and peritumoral regions for predicting CD3 expression in early cervical cancer.Scientific reports · 2025Article
- Intralesional and perilesional radiomics strategy based on different machine learning for the prediction of international society of urological pathology grade group in prostate cancer.BMC medical imaging · 2025Article
- Population-Specific Radiomics From Biparametric Magnetic Resonance Imaging Improves Prostate Cancer Risk Stratification in African American Men.JU open plus · 2025Article
- Preoperative model for predicting early recurrence in hepatocellular carcinoma patients using radiomics and deep learning: A multicenter study.World journal of gastrointestinal oncology · 2025Article
- MRMS-CNNFormer: A Novel Framework for Predicting the Biochemical Recurrence of Prostate Cancer on Multi-Sequence MRI.Bioengineering (Basel, Switzerland) · 2025Article
- Evaluating the feasibility of AI-predicted bpMRI image features for predicting prostate cancer aggressiveness: a multi-center study.Insights into imaging · 2025Article
- Prediction of bone metastasis of prostate cancer based on intratumoral and peritumoral radiomics of MRI T2WI combined with ADC images.Frontiers in oncology · 2025Article
- Interpretable machine learning model for predicting clinically significant prostate cancer: integrating intratumoral and peritumoral radiomics with clinical and metabolic features.BMC medical imaging · 2024Article
- Non-invasively identifying candidates of active surveillance for prostate cancer using magnetic resonance imaging radiomics.Visual computing for industry, biomedicine, and art · 2024Article
- Radiomic Pipelines for Prostate Cancer in External Beam Radiation Therapy: A Review of Methods and Future Directions.Journal of clinical medicine · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Ahmad AlgoharyDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH 44106, USA.
Rakesh ShiradkarDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH 44106, USA.
Shivani PahwaDepartment of Radiology, Case Western Reserve University, Cleveland, OH 44106, USA.
Andrei PuryskoSection of Abdominal Imaging and Nuclear Radiology Department, Cleveland Clinic, OH 44195, USA.ORCID 0000-0002-6888-0417
Sadhna VermaDepartment of Radiology, College of Medicine, University of Cincinnati, Cincinnati, OH 45221, USA.
Daniel MosesDepartment of Medicine, University of New South Wales, Sydney, NSW 2052, Australia.
Ronald ShnierDepartment of Medicine, University of New South Wales, Sydney, NSW 2052, Australia.ORCID 0000-0002-7300-5633
Anne-Maree HaynesCancer Division, The Kinghorn Cancer Centre/Garvan Institute of Medical Research, NSW 2010, Australia.
Warick DelpradoDouglass Hanly Moir Pathology, Sydney, NSW 2000, Australia.
James ThompsonDepartment of Medicine, University of New South Wales, Sydney, NSW 2052, Australia.ORCID 0000-0002-5115-9930
Sreeharsha TirumaniUrology Institute, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH 44106, USA.ORCID 0000-0002-5288-8916
Amr MahranUrology Institute, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH 44106, USA.ORCID 0000-0001-7586-0046
Ardeshir R RastinehadUrology at Lenox Hill and Northwell Health, New York, NY 10075, USA.
Lee PonskyUrology Institute, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH 44106, USA.
Phillip D StrickerDepartment of Medicine, University of New South Wales, Sydney, NSW 2052, Australia.
Anant MadabhushiDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH 44106, USA.ORCID 0000-0002-5741-0399
Funding
Oral Cavity Quantitative Histomorphometric Risk Classifier (OHbIC) in Oral Cavity Squamous Cell Carcinoma (OC-SCC)R01CA249992 · NCI · EMORY UNIVERSITY · PI LEWIS, JAMES, MADABHUSHI, ANANT · 2021 to 2025
$3.2MComputerized histologic image predictor of cancer outcomeR01CA202752 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI FELDMAN, MICHAEL D, GANESAN, SHRIDAR · 2016 to 2020
$3.1MQuantitative Histomorphometric Risk Classifier (QuHbIC) in HPV + Oropharyngeal CarcinomaR01CA220581 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI KOYFMAN, SHLOMO, LEWIS, JAMES · 2018 to 2023
$3.1MComputerized Histologic Risk Predictor (CHiRP) for Early Stage Lung CancersR01CA216579 · NCI · EMORY UNIVERSITY · PI FU, PINGFU, LLOYD, MARK · 2018 to 2023
$3.1MMR Fingerprinting and Computerized Decision Support for Prostate CancerR01CA208236 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GULANI, VIKAS, PONSKY, LEE EVAN · 2017 to 2022
$3.0MRadxTools for assessing tumor treatment response on imagingU01CA248226 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI TIWARI, PALLAVI, VISWANATH, SATISH EASWAR · 2020 to 2022
$1.4MHistoTools: A suite of digital pathology tools for quality control, annotation and dataset identificationU01CA239055 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI JANOWCZYK, ANDREW ROBERT, MADABHUSHI, ANANT · 2019 to 2022
$1.0MRadIO: A Novel Radiomics Toolkit to Predict and Characterize Response to Immunotherapy in Stage III Non-Small Cell Lung CancerI01BX004121 · VA · VETERANS HEALTH ADMINISTRATION · PI Anant Madabhushi, Charles J Nock · 2019 to 2026
–Foundation for the National Institutes of Health 1U24CA199374-01Foundation for the National Institutes of Health R01CA202752-01A1NCI NIH HHS R01 CA208236NCI NIH HHS R01 CA216579NCI NIH HHS R01 CA220581NCI NIH HHS R01 CA249992NCI NIH HHS U01 CA239055NCI NIH HHS U01 CA248226
Abstract
PubMed holds no abstract for this paper.
Indexed as
artificial intelligencemachine learningMRIperitumoral regionPIRADSprostate cancerradiomics
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.